Macular Edema (ME)
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema (NCT01846299) | Novartis Pharmaceuticals | 2013-10-01 |
Track Macular Edema (ME) automatically
Every clearance here is in the API, with alerts when new ones post.